Corporate leaders from OxyContin-maker Purdue Pharma expressed contrition on Thursday for their company’s role in fueling the opioid crisis amid a torrent of criticism from lawmakers of both parties over the drug manufacturer’s conduct.
Two members of the wealthy Sackler family who own OxyContin maker Purdue Pharma LP offered apologies on Thursday for the role the prescription painkiller has played in the deadly U.S. opioid epidemic but sought to deflect personal responsibility in response to withering criticism from lawmakers.
Two members of the Sackler family, heirs to the Purdue Pharma fortune built off the profits of the blockbuster pain drug OxyContin, expressed regret during a Congressional hearing on Thursday, though they did not admit wrongdoing.
Members of the Sackler family and Purdue Pharma's CEO say they did nothing wrong during the years their company illegally marketed Oxycontin and other opioids.
Two key House panels on Thursday announced a joint investigation into the massive cyberattack that has impacted multiple federal agencies, in what may be one of the most damaging digital intrusions in years.
In a surprise development, two members of the Sackler family who served on Purdue Pharma's board until 2018 are testifying Thursday morning under oath before the House Committee on Oversight and Reform.
Their privately owned company developed and aggressively marketed Oxycontin in the 1990s, growing into one of the nation's most profitable opioid producers.
Members of the family who own OxyContin maker Purdue Pharma are scheduled to make a rare appearance Thursday in a public forum, answering questions from a congressional panel about their role in the nation’s long-running opioid addiction crisis.